Migraine Behind Eye and Down Face: Evaluation and Management
This presentation is consistent with migraine with atypical facial pain localization, and you should treat it with standard migraine therapies—triptans are highly effective and should be your first-line acute treatment after NSAIDs, with response to triptans helping confirm the diagnosis.
Initial Evaluation: Rule Out Red Flags
Before diagnosing migraine, you must exclude secondary causes 1:
- Age >50 years at onset → consider temporal arteritis
- Fever, neck stiffness → meningitis or subarachnoid hemorrhage
- Focal neurological deficits → structural lesion
- Progressive worsening or change in pattern → secondary headache
If red flags are absent and neurological examination is normal, proceed with migraine management.
Understanding This Presentation
Migraine presenting with pain behind the eye radiating down the face is an atypical but recognized variant 2, 3. Key features that support migraine diagnosis:
- Strictly unilateral pain (79% of cases) 2
- Maxillary region involvement (85% of cases) 2
- Associated cranial autonomic symptoms (45% of cases—tearing, nasal congestion) 2
- Triptan responsiveness (77% response rate) 2
Critical pitfall: This pain pattern often mimics dental pain, leading to unnecessary dental procedures including extractions in 36% of misdiagnosed cases 4. Do not refer for dental work without first attempting migraine treatment.
Acute Treatment Algorithm
First-Line: NSAIDs 1, 5
- Ibuprofen 400-800 mg OR
- Aspirin 900-1000 mg OR
- Diclofenac potassium 50-100 mg
- Use early in attack for maximum effectiveness
Second-Line: Triptans 1, 5
Triptans are the diagnostic and therapeutic cornerstone for this presentation 2, 3, 4. They work in 77% of facial migraine cases 2:
- Sumatriptan 50-100 mg PO or 6 mg SC (subcutaneous highly effective in ED settings 6)
- Any triptan in the class is appropriate
- Consider combining with NSAIDs to prevent recurrence 1
Third-Line: Newer Agents 1, 5
- Gepants (CGRP receptor antagonists)
- Ditans (lasmiditan—avoid driving for 8 hours)
Adjunct Therapy
- Metoclopramide or domperidone for nausea/vomiting 1
Avoid Completely 1
- Opioids (including hydromorphone—level A evidence against use 6)
- Barbiturates
- Oral ergot alkaloids
Alternative Acute Intervention
For refractory cases in acute settings, greater occipital nerve blocks (GONB) are highly effective 6. The supraorbital and supratrochlear nerve blocks showed 82% success in relieving retro-ocular migraine attacks within 10-15 minutes 7.
When to Consider Prevention
Initiate preventive therapy if 1:
- Quality of life remains impaired despite optimized acute treatment
- Attacks occur ≥2 days per month with significant disability
- Overuse of acute medications develops
First-Line Preventive Options 5
- Topiramate or valproate
- Lisinopril or angiotensin-receptor blockers
- Propranolol (beta-blocker)
- Amitriptyline
Newer Preventive Options 5
- Atogepant or eptinezumab (CGRP monoclonal antibodies)
- Assess efficacy after 3-6 months for CGRP therapies 1
Diagnostic Confirmation Strategy
The response to triptans essentially confirms the diagnosis 2, 3, 4. If a patient with isolated facial pain responds to triptans, this strongly supports migraine even without typical headache location. This is a diagnosis of exclusion that should be made in the context of:
- Normal neurological examination
- No red flag features
- Stereotypical episodic pattern
- Positive triptan response
Key Clinical Pearls
- 66% of facial migraine cases are episodic (not chronic) 2
- This variant affects predominantly women (79%) 2
- The pain distribution follows trigeminal nerve territories (V2/V3) 3, 4
- Treatment is identical to standard migraine—location doesn't change management 4
- Consider multidisciplinary facial pain clinic referral for complex cases 2